Investigational Site Number 840002

Baltimore, Maryland 21230

0 studies enrolling now · 2 studies all time

What they study most

Prostate Cancer Metastatic, Solid Cancer

Studies at this site

• Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC) — Completed
• A Study to Evaluate the Effects of Combining Cabazitaxel With Cisplatin Given Every 3 Weeks in Patients With Advanced Solid Cancer — Completed